Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lara Pes"'
Autor:
K Abu Ajaj, Friederike I. Nollmann, P Perez Galan, S Chercheja, J Garcia Fernandez, Magnusson Johannes Pall, Steffen Daum, Koester Stephan David, Felix Kratz, Anna Warnecke, Lara Pes, Federico Medda
Publikováno v:
Nucl Med Mol Imaging
PURPOSE: The purpose of this study was to investigate the albumin-binding compound (111)In-C4-DTPA as an imaging agent for the detection of endogenous albumin accumulation in tumors. METHODS: (111)In-C4-DTPA was injected in healthy nude mice for phar
Autor:
Javier Garcia Fernandez, Anna Warnecke, Serghei Chercheja, Heidi-Kristin Walter, Lara Pes, Felix Kratz, Federico Medda, Friederike I. Nollmann, Didier Rognan, Steffen Daum, Khalid Abu Ajaj, Patricia Perez Galan, Magnusson Johannes Pall, Koester Stephan David
Publikováno v:
Journal of Controlled Release. 296:81-92
Auristatins are a class of highly cytotoxic tubulin-disrupting peptides, which have shown limited therapeutic effect as free agents in clinical trials. In our continuing effort to develop acid-sensitive albumin-binding anticancer drugs exploiting cir
Publikováno v:
Bioorganic & Medicinal Chemistry. 24:1706-1717
Cardiomyocytes are the major component of the heart. Their dysfunction or damage could lead to serious cardiovascular diseases, which have claimed numerous lives around the world. A molecule able to recognize cardiomyocytes would have significant val
Publikováno v:
Pediatric Surgery International. 31:37-43
Retinoids are essential for fetal and lung development. Beta-carotene(BC) is the main dietary retinoid source and beta-carotene-15,15′-oxygenase-1 and 2 (Bcmo1,2) is the primary enzyme generating retinoid from BC in adult mammalian tissues. Placent
Publikováno v:
Journal of Pediatric Surgery. 49:866-870
Background/Purpose The retinol signaling pathway is disrupted in congenital diaphragmatic hernia (CDH). Since there is no fetal retinol synthesis, maternal retinol has to cross the placenta. Nitrofen interferes with the retinol-binding protein (RBP)
Publikováno v:
Bioorganicmedicinal chemistry letters. 27(5)
A new dendrimer probe was designed for bone imaging. Bidentate iminodiacetate groups were introduced to the probe to obtain strong bind to bones. The assembled dendrimeric probe, with four iminodiacetate moieties and a fluorescent tag, displayed good
Autor:
Caitlin Jarrett, Yara C. Baxter, Johannes Boch, Conrado Carrasco, Daniel Cobos Muñoz, Karina Mauro Dib, Lara Pessoa, Jasmina Saric, Mariana Silveira, Peter Steinmann
Publikováno v:
Health Research Policy and Systems, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background The translation of evidence-based practices and rapid uptake of innovations into global health practice is challenging. Design thinking is a consultative process involving multiple stakeholders and has been identified as a promisi
Externí odkaz:
https://doaj.org/article/af19a4dc63794b668525c2431766008b
Autor:
Felix Kratz, Federico Medda, Javier Garcia Fernandez, Heidi-Kristin Walter, Serghei Chercheja, Anna Warnecke, Lara Pes, Patricia Perez Galan, Magnusson Johannes Pall, Friederike I. Nollmann, Khalid Abu Ajaj, Koester Stephan David
Publikováno v:
Cancer Research. 78:3703-3703
Auristatins are highly cytotoxic antimitotic tubulin-binding peptides. Of this family, only Adcetris®, an antibody drug conjugate (ADC) derived from monomethyl auristatin E (MMAE), is approved and marketed. Other auristatins such as dolastatin 10, d
Autor:
Felix Kratz, Federico Medda, Javier Garcia Fernandez, Heidi K. Walter, Friederike I. Nollmann, Lara Pes, Magnusson Johannes Pall, Koester Stephan David, Patricia Perez Galan, Khalid Abu Ajaj, Serghei Chercheja, Anna Warnecke
Publikováno v:
Cancer Research. 78:1657-1657
Introduction and objectives: Maytansine and its analogs (DM1 and DM4) are potent microtubule-targeting compounds that inhibit proliferation of cells during mitosis.1 Unfortunately, their narrow therapeutic window prevents a clinical application of th
Autor:
Javier Garcia Fernandez, Lara Pes, Heidi K. Walter, Friederike I. Nollmann, Federico Medda, Magnusson Johannes Pall, Felix Kratz, Anna Warnecke, Koester Stephan David, Serghei Chercheja, Patricia Perez Galan, Khalid Abu Ajaj
Publikováno v:
Cancer Research. 78:2661-2661
Introduction and objectives: Maytansine and its analogs (DM1 and DM4) are potent microtubule-targeting compounds that inhibit proliferation of cells during mitosis. Their potent anticancer activity made them attractive for drug development.1 Unfortun